Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Nektar Therapeutics, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Nektar Therapeutics June 5, 202490.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Nektar Therapeutics | Grant or award | +2,000 | — | — |
| Jun 14, 2023 | Nektar Therapeutics | Open-market sale | −30,000 | $0.57 | $17,100 |
Questions about Roy A. Whitfield
What boards is Roy A. Whitfield on?
Roy A. Whitfield sits on the board of Nektar Therapeutics.
How long has Roy A. Whitfield served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.